Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the {beta}2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial
Busse, W. W., O'Byrne, P. M., Bleecker, E. R., Lotvall, J., Woodcock, A., Andersen, L., Hicks, W., Crawford, J., Jacques, L., Apoux, L., Bateman, E. D.
Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the {beta}2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial